RABGGTB

Across TCGA pan-cancer cohorts, RABGGTB mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated RABGGTB data layer compared with 23 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RABGGTB mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated RABGGTB expression acts as an unfavorable survival marker, although some lineages such as UCEC and LSCC show a favorable association.

UCEC, CCRCC, and LUAD are the cancer types where RABGGTB mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	III,IV	1.000	0.449	.010	32	view →
CCRCC	DFS	Median	All	0.581	0.885	<.001	28	view →
LUAD	OS	Median	II,III,IV	0.280	0.800	.003	19	view →
LSCC	DFS	Median	III,IV	0.951	0.651	.024	8	view →
PDAC	OS	Median	All	0.579	0.397	.046	6	view →
HNSC	DFS	Quartile	III,IV	0.672	0.943	.039	2	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RABGGTB–UCEC (OS)

Open the UCEC breakdown →